H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$CYTOSORBENTS CORP(CTSO)$ 美东时间 2016-05-09 16:30 After Market Close:CYTOSORBENTS CP Earning Release . Wall St EPS Est ($):-0.09. 网页链接
$CYTOSORBENTS CORP(CTSO)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-25 AccNo: 0001144204-16-096010 Size: 332 KB 网页链接
$CYTOSORBENTS CORP(CTSO)$ DEF 14A - Other definitive proxy statements Filed: 2016-04-25 AccNo: 0001144204-16-096009 Size: 672 KB 网页链接
$CYTOSORBENTS CORP(CTSO)$ 美东时间 2016-04-12 13:40 Cytosorbents Corp at Needham Healthcare Conference 网页链接
$CYTOSORBENTS CORP(CTSO)$ 美东时间 2016-04-12 13:40 Cytosorbents Corp at Needham Healthcare Conference 网页链接
$CYTOSORBENTS CORP(CTSO)$ 8-K - Current report Filed: 2016-04-05 AccNo: 0001144204-16-092723 Size: 15 KBItem 8.01: Other Events 网页链接
$CYTOSORBENTS CORP(CTSO)$ 8-K - Current report Filed: 2016-03-16 AccNo: 0001144204-16-088327 Size: 14 KBItem 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics 网页链接
$CYTOSORBENTS CORP(CTSO)$ 8-K - Current report Filed: 2016-03-15 AccNo: 0001144204-16-088171 Size: 3 MBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$CYTOSORBENTS CORP(CTSO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-09 AccNo: 0001144204-16-086916 Size: 5 MB 网页链接
$CYTOSORBENTS CORP(CTSO)$ 美东时间 2016-03-09 16:30 After Market Close:CYTOSORBENTS CP Earning Release . Wall St EPS Est ($):-0.08. 网页链接